SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-174555
Filing Date
2014-05-01
Accepted
2014-05-01 07:40:25
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d708767d10q.htm 10-Q 561549
2 EX-10.1 d708767dex101.htm EX-10.1 22784
3 EX-10.2 d708767dex102.htm EX-10.2 16310
4 EX-31.1 d708767dex311.htm EX-31.1 9181
5 EX-31.2 d708767dex312.htm EX-31.2 9376
6 EX-32.1 d708767dex321.htm EX-32.1 3495
7 EX-32.2 d708767dex322.htm EX-32.2 3654
  Complete submission text file 0001193125-14-174555.txt   4142251

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT thld-20140331.xml EX-101.INS 680167
9 XBRL TAXONOMY EXTENSION SCHEMA thld-20140331.xsd EX-101.SCH 29667
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20140331_cal.xml EX-101.CAL 49547
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20140331_def.xml EX-101.DEF 100893
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20140331_lab.xml EX-101.LAB 277276
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20140331_pre.xml EX-101.PRE 201307
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 14801991
SIC: 2834 Pharmaceutical Preparations